Analysen von Keyur Parekh

02.04.20 Novartis Conviction Buy Goldman Sachs Group Inc.
30.03.20 Bayer buy Goldman Sachs Group Inc.
30.03.20 AstraZeneca Sell Goldman Sachs Group Inc.
24.03.20 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
19.03.20 Sanofi buy Goldman Sachs Group Inc.
17.03.20 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
16.03.20 Bayer buy Goldman Sachs Group Inc.
13.03.20 Roche Conviction Buy List Goldman Sachs Group Inc.
Werbung
12.03.20 AstraZeneca Sell Goldman Sachs Group Inc.
11.03.20 Roche Conviction Buy List Goldman Sachs Group Inc.
11.03.20 Sanofi buy Goldman Sachs Group Inc.
06.03.20 AstraZeneca Sell Goldman Sachs Group Inc.
05.03.20 Sanofi Neutral Goldman Sachs Group Inc.
27.02.20 Bayer buy Goldman Sachs Group Inc.
25.02.20 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
20.02.20 Roche buy Goldman Sachs Group Inc.
18.02.20 AstraZeneca Sell Goldman Sachs Group Inc.
06.02.20 Sanofi Neutral Goldman Sachs Group Inc.
06.02.20 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
05.02.20 GlaxoSmithKline buy Goldman Sachs Group Inc.
05.02.20 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
30.01.20 Roche buy Goldman Sachs Group Inc.
30.01.20 Novartis Conviction Buy List Goldman Sachs Group Inc.
29.01.20 Novartis Conviction Buy List Goldman Sachs Group Inc.
27.01.20 Roche buy Goldman Sachs Group Inc.
27.01.20 AstraZeneca Sell Goldman Sachs Group Inc.
24.01.20 Sanofi Neutral Goldman Sachs Group Inc.
24.01.20 Roche buy Goldman Sachs Group Inc.
24.01.20 Bayer buy Goldman Sachs Group Inc.
23.01.20 Roche buy Goldman Sachs Group Inc.
23.01.20 AstraZeneca Sell Goldman Sachs Group Inc.
22.01.20 Bayer buy Goldman Sachs Group Inc.
22.01.20 MorphoSys Neutral Goldman Sachs Group Inc.
22.01.20 Bayer buy Goldman Sachs Group Inc.
20.01.20 Novartis Conviction Buy Goldman Sachs Group Inc.
20.01.20 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
17.01.20 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
16.12.19 Novartis Conviction Buy List Goldman Sachs Group Inc.
10.12.19 Sanofi Neutral Goldman Sachs Group Inc.
09.12.19 Sanofi Neutral Goldman Sachs Group Inc.
06.12.19 Novartis Conviction Buy List Goldman Sachs Group Inc.
05.12.19 Sanofi Neutral Goldman Sachs Group Inc.
25.11.19 Novartis Conviction Buy Goldman Sachs Group Inc.
21.11.19 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
18.11.19 Bayer buy Goldman Sachs Group Inc.
18.11.19 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
11.11.19 Roche buy Goldman Sachs Group Inc.
06.11.19 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
04.11.19 Sanofi Neutral Goldman Sachs Group Inc.
04.11.19 Bayer buy Goldman Sachs Group Inc.
Seite: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | 13 Weiter

Analysensuche

GO
Werbung

Aktuelle News zu

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln